Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1992 2
1994 1
2000 1
2002 2
2003 1
2005 1
2007 3
2008 4
2009 3
2010 8
2011 5
2012 7
2013 9
2014 7
2015 5
2016 7
2017 8
2019 2
2020 3
2021 3
2022 3
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.
Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB. Brown AJH, et al. Among authors: hudson bd. Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001. Cell. 2021. PMID: 34822784 Free PMC article. Clinical Trial.
FFA4/GPR120: Pharmacology and Therapeutic Opportunities.
Milligan G, Alvarez-Curto E, Hudson BD, Prihandoko R, Tobin AB. Milligan G, et al. Among authors: hudson bd. Trends Pharmacol Sci. 2017 Sep;38(9):809-821. doi: 10.1016/j.tips.2017.06.006. Epub 2017 Jul 19. Trends Pharmacol Sci. 2017. PMID: 28734639 Free PMC article. Review.
Complex Pharmacology of Free Fatty Acid Receptors.
Milligan G, Shimpukade B, Ulven T, Hudson BD. Milligan G, et al. Among authors: hudson bd. Chem Rev. 2017 Jan 11;117(1):67-110. doi: 10.1021/acs.chemrev.6b00056. Epub 2016 Jun 14. Chem Rev. 2017. PMID: 27299848 Free article. Review.
SOST Inhibits Prostate Cancer Invasion.
Hudson BD, Hum NR, Thomas CB, Kohlgruber A, Sebastian A, Collette NM, Coleman MA, Christiansen BA, Loots GG. Hudson BD, et al. PLoS One. 2015 Nov 6;10(11):e0142058. doi: 10.1371/journal.pone.0142058. eCollection 2015. PLoS One. 2015. PMID: 26545120 Free PMC article.
Chemogenetics defines a short-chain fatty acid receptor gut-brain axis.
Barki N, Bolognini D, Börjesson U, Jenkins L, Riddell J, Hughes DI, Ulven T, Hudson BD, Ulven ER, Dekker N, Tobin AB, Milligan G. Barki N, et al. Among authors: hudson bd. Elife. 2022 Mar 1;11:e73777. doi: 10.7554/eLife.73777. Elife. 2022. PMID: 35229717 Free PMC article.
Treatment of type 2 diabetes by free Fatty Acid receptor agonists.
Watterson KR, Hudson BD, Ulven T, Milligan G. Watterson KR, et al. Among authors: hudson bd. Front Endocrinol (Lausanne). 2014 Aug 28;5:137. doi: 10.3389/fendo.2014.00137. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25221541 Free PMC article. Review.
82 results